## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ss-31-gut`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ss-31-gut/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-gut/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ss-31-gut/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-gut/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ss-31-gut/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ss-31-gut` v2 · content_hash `cb54f4766e31026d…` · thread_head genesis · 18 DIVs
- **thesis (c1):** SS-31 binds cardiolipin in the inner mitochondrial membrane and stabilizes cristae structure.
  - c3 [human/active] No human trials report effects of SS-31 on gut barrier function, permeability, or intestinal histology.
  - c2 [preclinical/active] In an in-vitro model, SS-31 reduced MPA-induced ROS, upregulated tight junction proteins, and lowered apoptosis in intestinal epithelial cells.
  - c4 [preclinical/active] LPS rodent models show SS-31 preserves mitochondrial function under inflammatory stress, though gut barrier endpoints were not measured.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ss-31-gut/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ss-31-gut/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ss-31-gut`
- **title:** SS-31 (Elamipretide) Mitochondrial Support for Gut: Evidence Review
- **url:** https://miscsubjects.com/a/ss-31-gut
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:04.241Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Gut barrier integrity depends on intestinal epithelial cells maintaining tight junctions and low oxidative stress. Mitochondrial dysfunction in these cells can increase reactive oxygen species, disrupt cardiolipin in the inner membrane, impair ATP production, and trigger apoptosis. This process weakens tight junction proteins such as ZO-1 and occludin. The result is higher paracellular permeability. Repair pathways that stabilize mitochondria can address the root layer rather than only downstream inflammation or symptoms.

## Why SS-31 (Elamipretide) might help you

If mitochondrial oxidative stress and cardiolipin instability form part of your gut barrier challenge, SS-31 (Elamipretide) is discussed because it binds cardiolipin directly. Step one: the peptide accumulates in the inner mitochondrial membrane. Step two: it stabilizes cristae structure and supports electron transport chain efficiency. Step three: this reduces electron leak and ROS production while preserving ATP output. Step four: lower ROS can limit apoptosis and support maintenance of tight junction proteins. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

## How these fit together

Single-compound focus. SS-31 (Elamipretide) maps to the mitochondrial layer of intestinal epithelial cell health. No sibling peptides are in scope for this review.

## What the evidence actually shows

Human data specific to gut: none identified. Preclinical data: one in-vitro study examined mycophenolic acid (MPA)-induced damage in intestinal epithelial cells. MPA increased ROS, reduced tight junction expression, and raised apoptosis. SS-31 treatment lowered intracellular and intramitochondrial ROS, upregulated tight junction proteins, and reduced apoptosis rates (preclinical tier, Deng et al. 2022, PMC9277164). Multiple rodent LPS models (LPS models systemic inflammation often linked to gut-derived endotoxins) showed SS-31 preserved mitochondrial membrane potential, reduced hippocampal oxidative stress, and improved behavioral outcomes, but these did not measure intestinal barrier endpoints directly (preclinical tier, Zhao et al. 2019). Broader mitochondrial studies in kidney and heart models confirm cardiolipin stabilization and ROS reduction in animal tissue (preclinical tier). No randomized human trials report gut permeability, microbiome, or intestinal histology outcomes.

## What scientists say

Researchers describe SS-31 as a cardiolipin-targeting tetrapeptide that improves bioenergetics without acting as a general antioxidant. Reviews note consistent mitochondrial protection across cell types in culture and rodents, with emphasis on cristae preservation and reduced cytochrome c release. Clinical development has focused on primary mitochondrial myopathy, heart failure, and Barth syndrome; gut-specific applications remain exploratory (mechanistic tier, multiple reviews 2024-2025).

## What people say on Reddit

Anecdotal reports in CFS and ME/CFS communities mention SS-31 primarily for energy and cognitive function. Some users note transient GI symptoms (nausea, diarrhea, hot flashes) during initial dosing that later resolved; others report no gut-specific benefits or changes. One user described fixing digestion first with other interventions before adding SS-31 for mitochondrial support (anecdotal tier, r/cfs threads 2025).

## What people say on X

Limited public discussion. Posts focus on mitochondrial medicine in general or Barth syndrome approval rather than gut outcomes. No widespread user reports tie SS-31 directly to intestinal barrier improvements (anecdotal tier).

## What we do not know

No human pharmacokinetic or efficacy data exist for intestinal epithelial mitochondria or gut permeability. Duration of effect on tight junctions, interactions with microbiome composition, and long-term outcomes in chronic gut conditions remain unstudied in controlled settings. Dose-response relationships specific to gut tissue are unknown.

## Safety and limits

Human trials in non-gut indications report good short-term tolerability with injection-site reactions as the main observation. Some preclinical and anecdotal sources note possible transient GI distress. Long-term human safety beyond trial durations is not established. Evidence for gut applications rests entirely on mechanistic and limited preclinical layers.

## Claims (4)

- **c4** [preclinical w=0.5] LPS rodent models show SS-31 preserves mitochondrial function under inflammatory stress, though gut barrier endpoints were not measured.
  - who_claims: grok/grok-4.3
  - sources: s4
- **c3** [human w=0.8] No human trials report effects of SS-31 on gut barrier function, permeability, or intestinal histology.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c2** [preclinical w=0.5] In an in-vitro model, SS-31 reduced MPA-induced ROS, upregulated tight junction proteins, and lowered apoptosis in intestinal epithelial cells.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c1** [mechanistic w=0.3] SS-31 binds cardiolipin in the inner mitochondrial membrane and stabilizes cristae structure.
  - who_claims: grok/grok-4.3
  - sources: s1

## Voxel graph (4 atoms · 8 edges)
- full graph: https://miscsubjects.com/api/articles/ss-31-gut/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `4c0cbe43ff1d7832`

### s1 · review · http_403
- title: Elamipretide: A Review of Its Structure, Mechanism, and Therapeutic Potential
- url: https://www.mdpi.com/1422-0067/26/3/944
- summary: Details cardiolipin binding and mitochondrial stabilization mechanism
- quote: Elamipretide (SS-31, MTP-131, Bendavia) is a mitochondria-targeting tetrapeptide designed to treat mitochondrial dysfunction via binding to cardiolipin (CL) on the inner mitochondrial membrane
- claim_ids: c1
- hash: `559041091a565c5a`

### s2 · pubmed · ok
- title: Mycophenolic Acid Induces the Intestinal Epithelial Barrier Dysfunction
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC9277164/
- summary: Direct preclinical evidence on intestinal epithelial cells
- quote: These results suggest that SS-31 protects the intestinal mechanical barrier and reduces apoptosis in vitro by inhibiting MPA-induced oxidative stress.
- claim_ids: c2
- hash: `93038c94e49bff66`

### s3 · review · ok
- title: SS-31 Peptide | Benefits, Safety & Buying Advice [2026]
- url: https://www.innerbody.com/ss-31-peptide
- summary: Confirms lack of human gut data across clinical development
- quote: Human trials focus on mitochondrial myopathy, heart failure, and renal artery stenosis; no gut-specific outcomes reported.
- claim_ids: c3
- hash: `7a4c2cf83e1cbdcb`

### s4 · pubmed · ok
- title: Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
- url: https://pubmed.ncbi.nlm.nih.gov/31747905/
- summary: LPS model with mitochondrial endpoints
- quote: Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment
- claim_ids: c4
- hash: `4c0cbe43ff1d7832`

## Provenance (2 model passes)
- chain valid: yes · head: `95964720ddc6a7bc`

- write · grok/grok-4.3 · 2026-06-29T23:54 · hash `9ef6e05d33e4`
- voxel_divide · owner · 2026-07-17T02:42 · hash `95964720ddc6`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ss-31-gut/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ss-31-gut/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ss-31-gut","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ss-31-gut|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ss-31-gut|tier|assertion`
- **iMessage ask:** `ss-31-gut|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ss-31-gut`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-gut/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*